71 results
Page 2 of 4
6-K/A
EX-99.2
0n1b7g r3r4
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
5:24pm
6-K
EX-99.2
iztqu
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
6-K
EX-99.2
ih5g0qms
5 Aug 21
Index to Unaudited Condensed Consolidated Financial Statements
6:04am
6-K
EX-99.2
v52geu16
6 May 21
Index to Unaudited Condensed Consolidated Financial Statements
6:03am
6-K
EX-1.1
unh9nklbll5rxmc7b
5 Mar 21
Current report (foreign)
8:15am
424B5
31s7t0y3 a0hxan5
5 Mar 21
Prospectus supplement for primary offering
7:55am
6-K
EX-1.1
upnnrpfhvthmam954
8 Sep 20
ObsEva Announces $20.0 Million Underwritten Offering and Concurrent Private Placement
7:40am
6-K
EX-5.2
i370mcgloc
8 Sep 20
ObsEva Announces $20.0 Million Underwritten Offering and Concurrent Private Placement
7:40am
424B5
13zmr80u hnp1
8 Sep 20
Prospectus supplement for primary offering
7:31am
6-K
EX-99.2
obg9mwz3
6 Aug 20
Index to Unaudited Condensed Consolidated Financial Statements
6:53am
6-K
EX-99.2
b23cp7ml3t4nm7v4t
5 May 20
Index to Unaudited Condensed Consolidated Financial Statements
6:01am
6-K
EX-99.1
kisdso2yu
6 Apr 20
ObsEva SA Announces New Interim Chief Financial Officer
4:00pm
6-K
EX-99.2
rvk9tra6 lhdeymmc
13 Nov 19
Index to Unaudited Condensed Consolidated Financial Statements
4:00pm
F-3
EX-5.2
lb3as w7pna
7 Aug 19
Shelf registration (foreign)
8:24am
F-3
EX-4.2
xfvl2cv4e7dnaieo
7 Aug 19
Shelf registration (foreign)
8:24am
F-3
EX-4.5
ykd375y
7 Aug 19
Shelf registration (foreign)
8:24am